Translation News and Research

RSS

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus.

24 Nov 2009

Financial results for the third-quarter reported by China Biologic Products

China Biologic Products, Inc. ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority- owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Guiyang Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today reported financial results for the third quarter ended September 30, 2009.

24 Nov 2009

Studies examine interaction of ribosome with molecular partners

Two new studies reveal in unprecedented detail how the ribosome interacts with other molecules to assemble new proteins and guide them toward their destination in biological cells. The studies used molecular dynamics flexible fitting (MDFF) to examine the interaction of the ribosome with two prominent molecular partners.

24 Nov 2009

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S.-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide.

24 Nov 2009

Scientists anticipate new approaches in drug development to combat prion infection

The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. With these findings, published in the current issue of the Journal of Biological Chemistry, scientists of Helmholtz Zentrum München and Technische Universität München anticipate new approaches in drug development to combat prion infection.

20 Nov 2009

Canadian Arthritis Network to host 2009 Annual Scientific Conference in Vancouver

People with arthritis and leading Canadian and international researchers will share the stage under the theme "Decoding Arthritis - A Joint Effort" when the Canadian Arthritis Network (CAN) hosts its 2009 Annual Scientific Conference beginning tonight, in Vancouver, BC.

19 Nov 2009

CMS report: House bill will raise health care costs, affect seniors' benefits

A new report from the Centers for Medicare and Medicaid Services finds that the health overhaul bill passed by the House will raise health costs by approximately $289 billion in the next ten years. The report was requested by House Republicans and compiled by CMS' chief actuary, Richard Foster.

16 Nov 2009

CMS report on House health bill: Many more insured means more, not less, spending

The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.

16 Nov 2009

El Camino Hospital moves into new, technologically and seismically advanced facility

El Camino Hospital, the hospital of Silicon Valley, today completed its move into the new, technologically and seismically advanced facility. After completing several practice runs led by the activation team, hospital officials report all patients were safely transferred to the new facility.

16 Nov 2009

Pharmos announces financial results for the third quarter of 2009

Pharmos Corporation today reported financial results for the third quarter and nine-month period ended September 30, 2009.

12 Nov 2009

Medical Facilities announces financial results for the third quarter of 2009

Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

12 Nov 2009

Video to improve patient-doctor communication

Amid growing concerns about racial, ethnic and language disparities in health care, The Joint Commission and the U.S. Department of Health and Human Services (HHS) Office for Civil Rights have released a video, entitled “Improving Patient-Provider Communication,” which supports language access in health care organizations.

12 Nov 2009

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

11 Nov 2009

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and Development Services (DDDS) company in India, through its subsidiary, Jubilant Biosys Limited, today signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by Duke scientists into clinical therapies.

11 Nov 2009

e-SMART-HD technology may help in closing health disparity gap

Sometimes patients find it uncomfortable asking a doctor of another age, gender or race for information. Hopefully virtual coaching under development through the Center of Excellence for Self-Management Advancement through Research and Translation ( SMART), a National Institutes of Health-funded Center of Research Excellence in Self-management Research at the Frances Payne Bolton School of Nursing at Case Western Reserve University, will improve communications.

11 Nov 2009

Cardiome Pharma announces financial results for the three months ended September 30, 2009

Cardiome Pharma Corp. today reported financial results for the third quarter ended September 30, 2009. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).

9 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Results of a long QT syndrome (LQTS) study published in the current issue of Circulation play an important role in understanding genetic testing's role in diagnosing disease, according to the senior author, Michael Ackerman, M.D., Ph.D. A pediatric cardiologist at Mayo Clinic, Dr. Ackerman directs Mayo's Long QT Syndrome Clinic and is the director of the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory.

6 Nov 2009

Garmin reports financial results for the third quarter of 2009

Garmin Ltd. today announced third quarter results for the period ended September 26, 2009.

From Garmin 4 Nov 2009

BD reports revenues of $1.898 billion for the fourth quarter of 2009

BD (Becton, Dickinson and Company) today reported quarterly revenues of $1.898 billion for the fourth fiscal quarter ended September 30, 2009, representing an increase of 5 percent from the prior-year period, or 8 percent excluding the unfavorable impact from foreign currency translation.

From BD (Becton, Dickinson and Company) 4 Nov 2009

Translation News and Research

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

Financial results for the third-quarter reported by China Biologic Products

Studies examine interaction of ribosome with molecular partners

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Scientists anticipate new approaches in drug development to combat prion infection

Canadian Arthritis Network to host 2009 Annual Scientific Conference in Vancouver

CMS report: House bill will raise health care costs, affect seniors' benefits

CMS report on House health bill: Many more insured means more, not less, spending

El Camino Hospital moves into new, technologically and seismically advanced facility

Pharmos announces financial results for the third quarter of 2009

Medical Facilities announces financial results for the third quarter of 2009

Video to improve patient-doctor communication

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

e-SMART-HD technology may help in closing health disparity gap

Cardiome Pharma announces financial results for the three months ended September 30, 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Garmin reports financial results for the third quarter of 2009

BD reports revenues of $1.898 billion for the fourth quarter of 2009

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News